Efficacy and Safety Study of Isuzinaxib in Subjects With DKD

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(20 sites)

South Korea

Korea University Ansan Hospital, Ansan-si

Inje university Busan Paik Hospital, Busan

Pusan National University Hospital, Busan

SoonChunHyang University Hospital Cheonan, Cheonan

Keimyung University Daegu Dongsan Hospital, Daegu

Inje university Ilsan Paik Hospital, Goyang-si

Hanyang University Guri Hospital, Guri-si

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong

The Catholic University of Korea Incheon St. Mary's Hospital, Incheon

Jeonbuk National University Hospital, Jeonju

CHA Bundang Medical Center, Seongnam-si

Boramae Medical Center, Seoul

Korea University Guro Hospital, Seoul

Kyung Hee University Hospital at Gangdon, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

The Catholic University of Korea Seoul ST.MARY'S Hospital, Seoul

The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu-si

Wonju Severance Christian Hospital, Wŏnju

Pusan National University Yangsan Hospital, Yangsan